These changes in gene expression are important in prostate carcinogenesis, considering that the down-regulation of PTEN is involved in the activation of anti-apoptotic pathways and strongly correlated with loss of androgen receptors, a common event in PC [37,38]. This evidence concerns the gene AR and pachyonychia congenita.